Search
Fulgent Genetics Inc
FLGTAdd to Watchlist
20.850USD
+0.030+0.14%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
601.54MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Fulgent Genetics Inc is 7.00, ranking 47 out of 75 in the Healthcare Providers & Services industry. The average price target is 35.00, with a high of 36.00 and a low of 30.00.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
15.000
Target Price
-27.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
8
Average
Company name
Ratings
Analysts
Fulgent Genetics Inc
FLGT
1
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Fulgent Genetics Inc's expected revenue for the next quarter?
Fulgent Genetics Inc's expected revenue is 94.00M.
What is Fulgent Genetics Inc's price target?
Analysts forecast that Fulgent Genetics Inc's price target is USD 35.00, with the highest forecast at USD 36.00 and the lowest forecast at USD 30.00.
How have Fulgent Genetics IncFLGT's recent earnings per share performed?
The market expectation was USD -0.80, while Fulgent Genetics IncFLGT's earnings per share (EPS) for the previous quarter was USD -0.76. EPS for the next quarter is expected at USD -0.46.
What is the analyst rating for Fulgent Genetics Inc?
Based on the ratings of Fulgent Genetics Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.